Teligent Pharma, Inc. is recalling 11,040 tubes of Erythromycin Topical Gel USP, 2% (30 g tube) because testing revealed the product contained unidentified related compounds that exceeded approved safety and quality limits. Erythromycin is a topical prescription antibiotic used to treat skin conditions like acne. This recall affects one specific lot of the gel manufactured in the United States.
Using medication that contains unknown impurities or degradation products may result in reduced effectiveness of the treatment or unexpected skin irritation. No incidents or adverse reactions have been reported to date in connection with this issue.
You have 2 options:
Recall #: D-0716-2022. Distributed by McKesson Corporation dba Sky Packaging.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.